The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
200 jobs Number of planned job losses
Announcement Date
3 December 2008
Employment effect (start)
3 December 2008
Foreseen end date
3 June 2010
Description
GlaxoSmithKline, a pharmaceutical company, is to cut 200 jobs from its factory in County Durham.The company will reduce the workforce at the plant from 950 to 750 over the next 18 months.The company stated that the reduction was not due to the current financial conditions, but because of the recent expiration of the patent on its anti-nausea drug Zofran, which is made at the factory, and competitors are now making their own version of the drug.
Sources
3 December 2008: The Guardian
3 December 2008: BBC News
Citation
Eurofound (2008), Glaxo Smith Kline, Internal restructuring in United Kingdom, factsheet number 67575, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/67575.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
